Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-FR Version v6-EN
Language French English
Date Updated 2018-06-04 2018-04-19
Drug Identification Number 02215756 02215756
Brand name CAVERJECT STERILE POWDER - KIT 23.2MCG/VIAL CAVERJECT STERILE POWDER - KIT 23.2MCG/VIAL
Common or Proper name Caverject Caverject
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients WATER ALPROSTADIL WATER ALPROSTADIL
Strength(s) 99.1% 23.2MCG 99.1% 23.2MCG
Dosage form(s) KIT LIQUID POWDER FOR SOLUTION KIT LIQUID POWDER FOR SOLUTION
Route of administration INTRACAVERNOSAL INTRACAVERNOSAL
Packaging size 5 x 20MCG 5 x 20MCG
ATC code G04BE G04BE
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2018-04-18
Actual start date 2018-04-20
Estimated end date 2018-06-15
Actual end date 2018-06-01
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments